WO2005079818A1 - Glycerol solution containing dissolved ozone, solidified glycerol containing dissolved ozone, mixed solution containing dissolved ozone, process for producing glycerol solution containing dissolved ozone, process for producing mixed solution containing dissolved ozone, and method of storing glycerol solution containing diss - Google Patents

Glycerol solution containing dissolved ozone, solidified glycerol containing dissolved ozone, mixed solution containing dissolved ozone, process for producing glycerol solution containing dissolved ozone, process for producing mixed solution containing dissolved ozone, and method of storing glycerol solution containing diss Download PDF

Info

Publication number
WO2005079818A1
WO2005079818A1 PCT/JP2005/002570 JP2005002570W WO2005079818A1 WO 2005079818 A1 WO2005079818 A1 WO 2005079818A1 JP 2005002570 W JP2005002570 W JP 2005002570W WO 2005079818 A1 WO2005079818 A1 WO 2005079818A1
Authority
WO
WIPO (PCT)
Prior art keywords
ozone
dissolved
solution containing
glycerin
dissolved ozone
Prior art date
Application number
PCT/JP2005/002570
Other languages
French (fr)
Japanese (ja)
Inventor
Akihiko Shiba
Gotaro Shiota
Original Assignee
Vmc Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vmc Co., Ltd. filed Critical Vmc Co., Ltd.
Publication of WO2005079818A1 publication Critical patent/WO2005079818A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/40Peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Abstract

A glylcerol solution containing dissolved ozone which is an at least 75 wt.% non-oxidizing glycerol solution containing ozone in an amount of at least 400 ppm. The solution can retain over long an ozone concentration sufficient for exhibiting a bactericidal effect. By mixing the glylcerol solution containing dissolved ozone with any one of water, vaseline, and polyethylene glycol, the irritant properties of glycerol can be reduced. Furthermore, by mixing the glylcerol solution containing dissolved ozone with any one of water, vaseline, and polyethylene glycol and stirring the mixture, a mixed solution containing dissolved ozone can be produced which retains intact oxidizing ability and contains no harmful oxides (peroxides).

Description

明 細 書  Specification
オゾン溶存グリセリン溶液、オゾン溶存グリセリン固化物、オゾン溶存混合 溶液、オゾン溶存グリセリン溶液の製造方法、オゾン溶存混合溶液の製造方法、 及びオゾン溶存グリセリン溶液の保存方法  Ozone-dissolved glycerin solution, solidified ozone-dissolved glycerin, ozone-dissolved mixed solution, method for producing ozone-dissolved glycerin solution, method for producing ozone-dissolved mixed solution, and method for storing ozone-dissolved glycerin solution
技術分野  Technical field
[0001] この発明は、オゾン溶存グリセリン溶液、オゾン溶存グリセリン固化物、オゾン溶存 混合溶液、オゾン溶存グリセリン溶液の製造方法、オゾン溶存混合溶液の製造方法 、及びオゾン溶存グリセリン溶液の保存方法に関する。  The present invention relates to an ozone-dissolved glycerin solution, an ozone-dissolved glycerin solid, an ozone-dissolved mixed solution, a method for producing an ozone-dissolved glycerin solution, a method for producing an ozone-dissolved mixed solution, and a method for storing an ozone-dissolved glycerin solution.
背景技術  Background art
[0002] オゾンには強力な酸ィ匕作用があり、殺菌に役立つことが各種研究により実証されて いる。気体のオゾンの一般的な製造方法としては、空気に放電して一部をオゾンィ匕 する方法がある。  [0002] Various studies have demonstrated that ozone has a strong iridescent effect and is useful for sterilization. As a general method for producing gaseous ozone, there is a method of discharging a part of air to ozone.
[0003] また、気体のオゾンの他に、オゾンを水に溶け込ませたオゾン水も利用されて 、る。  [0003] In addition to gaseous ozone, ozone water in which ozone is dissolved in water is also used.
オゾン水の製造方法としては、空気を放電して製造したオゾンを何らかの方法で水に 溶かし込む方法や、白金等のオゾン生成触媒機能を有する電極を用いて水を直接 電気分解し、発生する酸素の一部をオゾンィ匕し、即座に水に溶け込ませるものがある  The method of producing ozone water includes dissolving ozone produced by discharging air into water by some method, and oxygen generated by directly electrolyzing water using an electrode having an ozone generation catalytic function such as platinum. Some parts are ozone-ridden and immediately dissolved in water
[0004] この他に、濃度 0. 01— 500ppmのオゾンを含む気体をオゾン発生器で発生させ、 これを粘度が 1一 106Pa · sの液体に溶解またはマイクロバブル化して封入したオゾン 封入粘稠体が知られている。気体のオゾンやオゾン水には定着性がないため、用途 が限られていた力 オゾン封入粘稠体により、クリームやペーストとして特定の部位に 定着させオゾンを作用させることができる (特許文献 1参照)。 [0004] In addition, a gas containing ozone at a concentration 0. 01- 500 ppm generated in an ozone generator, ozone inclusion of this viscosity was encapsulated by dissolving or micro-bubbles into the liquid 1 one 10 6 Pa · s A viscous body is known. Since gaseous ozone and ozone water do not have fixability, the ozone encapsulating viscous material, which had limited use, can fix it as a cream or paste on a specific site and cause ozone to act (see Patent Document 1). ).
特許文献 1:特開平 10— 139645号公報  Patent Document 1: Japanese Patent Application Laid-Open No. 10-139645
発明の開示  Disclosure of the invention
発明が解決しょうとする課題  Problems to be solved by the invention
[0005] ところで、オゾン封入粘稠体を実際に殺菌剤として使用する創傷部位には、オゾン を使用する被酸化物 (有機物、血液等)が多数存在するため、高濃度のオゾンが溶 存している必要があり、終濃度で 80ppm程度のオゾン濃度が必要である。しかし、上 記のオゾン封入粘稠体では、濃度 0. 01— 500ppmのオゾンを含む気体を、粘度が 1一 106Pa' sの液体に溶解またはマイクロバブル化して封入するため、オゾンの終濃 度が極めて低くなり、実用に適したものとなっていなかった。 [0005] By the way, at the wound site where the ozone-enclosed viscous material is actually used as a disinfectant, a large number of oxides (organic substances, blood, etc.) using ozone are present, so that a high concentration of ozone is dissolved. Ozone concentration of about 80 ppm in final concentration is required. However, in the above SL ozone inclusion viscosity稠体of a gas containing ozone at a concentration 0. 01- 500 ppm, the viscosity is sealed by dissolving or micro-bubbles into the liquid 1 one 10 6 Pa 's, ozone end of The concentration was extremely low and was not suitable for practical use.
[0006] また、オゾン封入粘稠体の製造直後のオゾン濃度が低い場合には、保管期間が長 くなるとオゾン濃度が低下し、殺菌効果を維持することができな力つた。また、粘稠体 の種類によっては、オゾンに酸化されて有害な酸化物 (過酸化物)が生じる恐れもあ つた o [0006] In addition, when the ozone concentration immediately after the production of the ozone-enclosed viscous body is low, the ozone concentration decreases when the storage period is prolonged, and the sterilization effect cannot be maintained. In addition, depending on the type of viscous material, it may be oxidized by ozone to produce harmful oxides (peroxides).
[0007] 本発明の課題は、殺菌効果及び創傷治癒効果を発揮するのに充分なオゾン濃度 を長期間維持するとともに、有害な酸ィ匕物 (過酸ィ匕物)が生じないオゾン溶存グリセリ ン溶液、オゾン溶存グリセリン固化物、オゾン溶存混合溶液、オゾン溶存グリセリン溶 液の製造方法、オゾン溶存混合溶液の製造方法、及びオゾン溶存グリセリン溶液の 保存方法を提供することである。  [0007] An object of the present invention is to maintain an ozone concentration sufficient for exhibiting a bactericidal effect and a wound healing effect for a long period of time, and to produce ozone-dissolved glycerol that does not generate harmful oxidants. The present invention provides a method for producing an ozone-dissolved glycerin solution, a method for producing an ozone-dissolved mixed solution, a method for producing an ozone-dissolved mixed solution, and a method for storing an ozone-dissolved glycerin solution.
課題を解決するための手段  Means for solving the problem
[0008] 以上の課題を解決するため、請求の範囲第 1項に記載の発明は、オゾン溶存グリ セリン溶液であって、 75wt%以上の非酸化のグリセリン溶液にオゾンが 400ppm以 上溶存して ヽることを特徴とする。 [0008] In order to solve the above problems, the invention described in claim 1 is an ozone-dissolved glycerin solution, wherein at least 400 ppm of ozone is dissolved in a 75 wt% or more non-oxidized glycerin solution. It is characterized by
[0009] 請求の範囲第 1項に記載の発明によれば、高濃度で非酸ィ匕のグリセリンにオゾンが 高濃度で溶存しているため、殺菌効果を発揮するのに充分なオゾン濃度を長期間保 持することができる。 [0009] According to the invention set forth in claim 1, ozone is dissolved at a high concentration in the non-oxidizing glycerin at a high concentration, so that an ozone concentration sufficient to exhibit a bactericidal effect is obtained. It can be kept for a long time.
[0010] 請求の範囲第 2項に記載の発明は、オゾン溶存混合溶液であって、 75wt%以上 の非酸ィ匕のグリセリン溶液にオゾン力 OOppm以上溶存しているオゾン溶存グリセリ ン溶液を水、ワセリン、ポリエチレングリコールのいずれか 1つと混合してなり、オゾン が 80ppm以上溶存して 、ることを特徴とする。  [0010] The invention described in claim 2 is an ozone-dissolved mixed solution, wherein an ozone-dissolved glycerin solution having an ozone power of OO ppm or more dissolved in a non-oxidized glycerin solution of 75 wt% or more is treated with water. Ozone is dissolved in at least 80 ppm by mixing with any one of petroleum, petrolatum, and polyethylene glycol.
[0011] 高濃度のグリセリンには肌への刺激性があるため、化粧水や美容液に利用する場 合には、グリセリンの濃度を低下させる必要がある力 請求の範囲第 2項に記載の発 明によれば、オゾン溶存グリセリン溶液を水、ワセリン、ポリエチレングリコールのいず れか 1つと混合することで、グリセリンの刺激性を抑えることができる。また、オゾンが 8 Oppm以上溶存しているため、充分な殺菌能力を発揮することができる。 [0011] The high concentration of glycerin is irritating to the skin, and therefore, when used in a lotion or a serum, it is necessary to reduce the concentration of glycerin. According to the invention, the irritation of glycerin can be suppressed by mixing the ozone-dissolved glycerin solution with one of water, vaseline, and polyethylene glycol. In addition, ozone Since Oppm or more is dissolved, sufficient sterilization ability can be exhibited.
[0012] なお、オゾンを水に溶解させた後にオゾン水にグリセリンをカ卩えると、グリセリン濃度 に依存して速やかに酸ィ匕力が消失するが、オゾンをグリセリンに溶存させた後にォゾ ン溶存グリセリン溶液を水で希釈しても酸化力が失われない。 [0012] When glycerin is added to ozone water after dissolving ozone in water, the oxidizing power rapidly disappears depending on the glycerin concentration. The oxidizing power is not lost even when the dissolved glycerin solution is diluted with water.
[0013] また、ワセリンやポリエチレングリコールを高濃度のオゾンと気液接触させる場合に は、有害な酸ィ匕物 (過酸ィ匕物)が生じる力 高濃度のグリセリンに高濃度のオゾンを溶 存させてから、ワセリンまたはポリエチレングリコールと混合する場合には、有害な酸 化物 (過酸ィ匕物)が生じない。したがって、オゾン溶存グリセリン溶液に、水、ワセリン 、ポリエチレングリコールのいずれか 1つを混合し、攪拌することで、酸化力の失われ な ヽ、また有害な酸化物 (過酸化物)を含まな ヽオゾン溶存混合溶液を製造すること ができる。 [0013] In addition, when vaseline or polyethylene glycol is brought into gas-liquid contact with high-concentration ozone, a high concentration of glycerin is dissolved in high-concentration glycerin, which causes harmful oxidization (peroxidation). When mixed with petrolatum or polyethylene glycol after having been allowed to exist, no harmful oxides (peroxides) are generated. Therefore, by mixing any one of water, petrolatum, and polyethylene glycol with the ozone-dissolved glycerin solution and stirring the mixture, the oxidizing power is not lost and no harmful oxides (peroxides) are contained. An ozone-dissolved mixed solution can be produced.
[0014] 請求の範囲第 3項に記載の発明は、オゾン溶存グリセリン溶液の製造方法であって [0014] The invention described in claim 3 is a method for producing an ozone-dissolved glycerin solution.
、 75wt%以上のグリセリン溶液に、オゾンを含むガスを気液接触させてオゾンを 400 ppm以上溶存させることを特徴とする。 A gas containing ozone is brought into gas-liquid contact with a glycerin solution of 75% by weight or more to dissolve ozone of 400 ppm or more.
[0015] 請求の範囲第 3項に記載の発明によれば、 75wt%以上のグリセリン溶液に、ォゾ ンを含むガスを気液接触させることで、高濃度のグリセリンにオゾンを高濃度で溶存さ せたオゾン溶存グリセリン溶液を製造することができる。 [0015] According to the invention set forth in claim 3, ozone is dissolved in high-concentration glycerin at a high concentration by bringing a gas containing ozone into gas-liquid contact with a glycerin solution of 75 wt% or more. An ozone-dissolved glycerin solution can be produced.
[0016] 請求の範囲第 4項に記載の発明は、オゾン溶存混合溶液の製造方法であって、 75 wt%以上のグリセリン溶液にオゾンを含むガスを気液接触させてオゾンを 400ppm 以上溶存させ、これと、水、ワセリン、ポリエチレングリコールのいずれ力 1つとを混合 し、攪拌することでオゾンを 80ppm以上溶存させることを特徴とする。 [0016] The invention described in claim 4 is a method for producing an ozone-dissolved mixed solution, wherein a gas containing ozone is brought into gas-liquid contact with a glycerin solution of 75 wt% or more to dissolve 400 ppm or more of ozone. It is characterized in that ozone is dissolved by 80 ppm or more by mixing and stirring with any one of water, petrolatum and polyethylene glycol.
[0017] 請求の範囲第 4項に記載の発明によれば、請求の範囲第 2項に記載の発明と同様 の効果を得ることができる。 [0017] According to the invention set forth in claim 4, it is possible to obtain the same effect as the invention set forth in claim 2.
[0018] 請求の範囲第 5項に記載の発明は、オゾン溶存グリセリン溶液の保存方法であって[0018] The invention described in claim 5 is a method for storing an ozone-dissolved glycerin solution.
、非酸ィ匕のグリセリン溶液にオゾンが溶存しているオゾン溶存グリセリン溶液を、冷蔵 保存または冷凍保存することを特徴とする。 The ozone-dissolved glycerin solution in which ozone is dissolved in the non-oxidizing glycerin solution is stored refrigerated or frozen.
[0019] ここで、冷蔵保存とは、 5°C以上 10°C以下で保存することであり、冷凍保存とは、[0019] Here, refrigerated storage is to store at 5 ° C or more and 10 ° C or less, and frozen storage is
5°C以下で保存することである。なお、オゾン溶存グリセリン溶液のグリセリン濃度や オゾン濃度は任意である。 Store at 5 ° C or less. The glycerin concentration of the ozone-dissolved glycerin solution and The ozone concentration is arbitrary.
[0020] 請求の範囲第 5項に記載の発明によれば、非酸ィ匕のグリセリン溶液にオゾンが溶存 しているオゾン溶存グリセリン溶液を、冷蔵保存または冷凍保存することで、常温保 存するよりもオゾン濃度を長期間、高濃度に維持することができる。  [0020] According to the invention set forth in claim 5, the ozone-dissolved glycerin solution in which ozone is dissolved in the non-oxidizing glycerin solution is stored at room temperature by refrigeration or freezing. Can also maintain the ozone concentration at a high concentration for a long time.
[0021] 請求の範囲第 6項に記載の発明は、オゾン溶存グリセリン固化物であって、非酸ィ匕 のグリセリン溶液にオゾンが溶存して 、るオゾン溶存グリセリン溶液を冷却し、固化さ せたことを特徴とする。  The invention described in claim 6 is an ozone-dissolved glycerin solidified product, wherein ozone is dissolved in a non-oxidizing glycerin solution, and the ozone-dissolved glycerin solution is cooled and solidified. It is characterized by having.
[0022] ここで、オゾン溶存グリセリン固化物は、冷却し、固化した状態のオゾン溶存グリセリ ン溶液であり、グリセリンが結晶化して固化していてもよいし、過冷却状態になり溶液 全体の粘性が高くなつて固化していてもよい。また、グリセリンが単独で固化していて もよいし、溶液を構成する他の成分とともに固化していてもよい。なお、オゾン溶存グ リセリン溶液のグリセリン濃度やオゾン濃度は任意である。  Here, the solidified ozone-dissolved glycerin is an ozone-dissolved glycerin solution in a cooled and solidified state, and glycerin may be crystallized and solidified, or may be supercooled and become viscous in the entire solution. May be high and solidified. Further, glycerin may be solidified alone, or may be solidified together with other components constituting the solution. The glycerin concentration and ozone concentration of the ozone-dissolved glycerin solution are arbitrary.
[0023] 請求の範囲第 6項に記載の発明によれば、非酸ィ匕のグリセリン溶液にオゾンが溶存 して 、るオゾン溶存グリセリン溶液が冷却されて固化して 、るため、液体の状態よりも オゾンを放出しにくぐオゾン濃度をより長期間、高濃度に維持することができる。 発明の効果  [0023] According to the invention set forth in claim 6, ozone is dissolved in the non-oxidized glycerin solution, and the ozone-dissolved glycerin solution is cooled and solidified. It is possible to maintain a high concentration of ozone for a longer period of time, because ozone is not easily released. The invention's effect
[0024] 本発明によれば、高濃度のグリセリン溶液に高濃度のオゾンを溶存させているため According to the present invention, high concentration ozone is dissolved in high concentration glycerin solution.
、オゾン溶存グリセリン溶液中のオゾンの溶存濃度を、殺菌剤等に用いるのに充分な 濃度で長期間維持することができる。 In addition, the dissolved concentration of ozone in the ozone-dissolved glycerin solution can be maintained for a long time at a concentration sufficient for use as a disinfectant or the like.
[0025] また、オゾン溶存グリセリン溶液を、水、ワセリン、ポリエチレングリコールのいずれか と混合するため、酸ィ匕力の失われない、また有害な酸ィ匕物 (過酸ィ匕物)を含まないォ ゾン溶存混合溶液を製造することができる。 [0025] Further, since the ozone-dissolved glycerin solution is mixed with any of water, vaseline, and polyethylene glycol, the ozone-dissolving power is not lost, and a harmful odonide (peroxydani) is included. No ozone-dissolved mixed solution can be produced.
[0026] また、オゾン溶存グリセリン溶液を冷蔵保存または冷凍保存することで、常温保存 するよりもオゾン濃度を長期間、高濃度に維持することができる。また、オゾン溶存グ リセリン溶液を冷却して固化することで、液体の状態よりもオゾンが放出されに《し、 オゾン濃度をより長期間、高濃度に維持することができる。 [0026] Further, by storing the ozone-dissolved glycerin solution in a refrigerated or frozen state, the ozone concentration can be maintained at a high level for a long period of time as compared with the case of storing it at room temperature. Further, by cooling and solidifying the ozone-dissolved glycerin solution, ozone is released from the liquid state, and the ozone concentration can be maintained at a high level for a longer period of time.
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0027] 以下、本発明の実施の形態について詳細に説明する。本発明のオゾン溶存グリセ リン溶液は、高濃度のグリセリン溶液とオゾン濃度の高 ヽ気体とを気液接触させること で製造することができる。 Hereinafter, embodiments of the present invention will be described in detail. Ozone dissolved glycer of the present invention A phosphorus solution can be produced by bringing a high-concentration glycerin solution and a high-ozone-concentration gas into gas-liquid contact.
[0028] オゾン濃度の高い気体は、例えば酸素ガスに無声放電することでオゾンを生成する オゾン発生装置で製造することができる。酸素ガスを用いる場合には、医療用の酸素 ボンべを用いてもょ 、し、また酸素発生装置で製造された酸素ガスを用いてもょ 、。 空気を用いると、窒素酸化物が生成される。空気を用いてオゾン濃度の高い気体を 生成し、ヨウ化カリウム適定法でオゾン濃度を測定すると、ヨウ化カリウム消費量が見 かけ上増加するが、これは窒素酸ィ匕物のためである。窒素酸化物は有害物質である ため、空気を用いる方法は実際の使用に適さない。  [0028] A gas having a high ozone concentration can be produced by, for example, an ozone generator that generates ozone by silently discharging oxygen gas. When oxygen gas is used, a medical oxygen cylinder may be used, or oxygen gas produced by an oxygen generator may be used. With air, nitrogen oxides are produced. When a gas with a high ozone concentration is generated using air and the ozone concentration is measured by the potassium iodide titration method, the apparent consumption of potassium iodide increases, but this is due to nitrogen oxide. Since nitrogen oxides are harmful substances, the method using air is not suitable for actual use.
[0029] 高濃度のグリセリン溶液としては、グリセリン濃度 75wt%以上のグリセリン溶液を用 いることができるが、 日本薬局方品の 84— 87wt%のグリセリンが好ましぐ 日本薬局 方品のグリセリン濃度 98wt%以上の濃グリセリンを用いることがより好ましい。また、 濃度 98. 5wt%以上の精製グリセリンを用いることがさらに好ましい。グリセリン濃度 が高いと、オゾンをより高濃度に溶存させることができるからである。  [0029] As the high-concentration glycerin solution, a glycerin solution having a glycerin concentration of 75% by weight or more can be used. A glycerin concentration of 84 to 87% by weight of the Japanese Pharmacopoeia is preferred. It is more preferred to use concentrated glycerin of at least%. Further, it is more preferable to use purified glycerin having a concentration of 98.5 wt% or more. This is because if the glycerin concentration is high, ozone can be dissolved at a higher concentration.
[0030] 高濃度のグリセリン溶液とオゾン濃度の高 、気体とを気液接触させる方法としては、 例えばタンクに高濃度 (例えば 98wt%以上)のグリセリン溶液を入れ、散気管を用い てタンク内にオゾン濃度の高い気体を微細な気泡として放出する方法がある。例えば 、オゾン濃度 80gZkL (約 37000ppm)の気体を濃グリセリン中に約 7日間曝気する ことにより、オゾン濃度約 3000ppmのオゾン溶存グリセリン溶液を製造することができ る。  [0030] As a method of bringing a high-concentration glycerin solution into contact with a gas having a high ozone concentration and a gas, for example, a high-concentration (for example, 98 wt% or more) glycerin solution is put into a tank, and the tank is filled with a diffuser tube. There is a method of discharging a gas having a high ozone concentration as fine bubbles. For example, an ozone-dissolved glycerin solution having an ozone concentration of about 3000 ppm can be produced by aerating a gas having an ozone concentration of 80 gZkL (about 37,000 ppm) in concentrated glycerin for about 7 days.
[0031] オゾンの終濃度はグリセリン濃度に依存して定まり、前述の方法の場合、グリセリン 濃度 75wt%ではオゾンの終濃度は約 400ppm、グリセリン濃度 85wt%ではオゾン の終濃度は約 500ppm、グリセリン濃度 90wt%ではオゾンの終濃度は約 lOOOppm 、グリセリン濃度 98wt%ではオゾンの終濃度は約 3000ppmとなる。  [0031] The final concentration of ozone is determined depending on the glycerin concentration. In the case of the above-described method, the final concentration of ozone is approximately 400 ppm at a glycerin concentration of 75 wt%, and the final concentration of ozone is approximately 500 ppm at a glycerin concentration of 85 wt%. At 90 wt%, the final concentration of ozone is about 100 ppm, and at 98 wt% of glycerin, the final concentration of ozone is about 3000 ppm.
[0032] 最終的に得られるオゾン溶存グリセリン溶液は、グリセリン濃度 75wt%以上でォゾ ン濃度 400ppm以上であることが好ましぐグリセリン濃度 80wt%以上でオゾン濃度 500ppm以上であることがより好ましぐグリセリン濃度 90wt%以上でオゾン濃度 10 OOppm以上であることがさらに好ましぐグリセリン濃度 98wt%以上でオゾン濃度 30 OOppm以上であることが最も好ましい。グリセリンが高濃度であるほど、オゾンを高濃 度にすることができ、殺菌効果及び創傷治癒効果を高めることができるとともに、ォゾ ン濃度を長期間にわたり維持することができる力もである。このように製造されたォゾ ン溶存グリセリン溶液は、オゾンの初期濃度が高濃度であり、後述するようにオゾン濃 度の半減期が長くなり、殺菌剤として必要なオゾン濃度を長期間にわたり維持するこ とがでさる。 [0032] The finally obtained ozone-dissolved glycerin solution preferably has a glycerin concentration of 75 wt% or more and an ozone concentration of 400 ppm or more, more preferably a glycerin concentration of 80 wt% or more and an ozone concentration of 500 ppm or more. More preferably, the ozone concentration is 10 OOppm or more when the glycerin concentration is 90 wt% or more.The ozone concentration is 30 when the glycerin concentration is 98 wt% or more. Most preferably, it is at least OO ppm. The higher the concentration of glycerin, the higher the concentration of ozone, the higher the bactericidal and wound healing effects, and the ability to maintain the ozone concentration over a long period of time. The ozone-dissolved glycerin solution produced in this way has a high initial concentration of ozone, has a long half-life of ozone concentration as described later, and maintains the ozone concentration required as a disinfectant for a long period of time. You can do it.
[0033] また、オゾン濃度の半減期が長いことからわ力るように、このオゾン溶存グリセリン溶 液力 放出されるオゾンの量は極めて少ない。したがって、オゾン溶存グリセリン溶液 の使用部位、到達部位においてオゾンを少しずつ長期間にわたり放出させることが できる。また、放出されるオゾンの量が極めて少ないため、このオゾン溶存グリセリン 溶液は、高濃度のオゾンが溶存しているのにもかかわらず、全くオゾン臭がしない。  [0033] Further, as is evident from the long half-life of the ozone concentration, the amount of ozone released from the ozone-dissolved glycerin solution is extremely small. Therefore, ozone can be gradually released over a long period of time at the use site and the arrival site of the ozone-dissolved glycerin solution. Further, since the amount of released ozone is extremely small, this ozone-dissolved glycerin solution does not have an ozone smell at all even though a high concentration of ozone is dissolved.
[0034] なお、オゾン溶存グリセリン溶液を 5°C以上 10°C以下で冷蔵保存または 5°C以 下で冷凍保存することで、オゾン溶存グリセリン溶液力 放出されるオゾンの量をさら に少なくすることができ、常温保存するよりもオゾン濃度をより長期間、高濃度に維持 することができる。  [0034] The ozone-dissolved glycerin solution is refrigerated at 5 ° C to 10 ° C or frozen at 5 ° C or less to further reduce the amount of ozone released. Therefore, the ozone concentration can be maintained at a high level for a longer period of time than when stored at room temperature.
[0035] 特に、オゾン溶存グリセリン溶液を冷却してオゾン溶存グリセリン固化物とした場合 には、液体の状態よりもオゾンが放出されにくぐオゾン濃度をより長期間、高濃度に 維持することができる。ここで、オゾン溶存グリセリン固化物は、冷却し、固化した状態 のオゾン溶存グリセリン溶液であり、グリセリンが結晶化して固化していてもよいし、過 冷却状態になり溶液全体の粘性が高くなつていてもよい。また、グリセリンが単独で固 化して 、てもよ 、し、溶液を構成する他の成分とともに固化して 、てもよ 、。  [0035] In particular, when the ozone-dissolved glycerin solution is cooled to be a solidified ozone-dissolved glycerin solution, it is possible to maintain the ozone concentration at which ozone is released more easily than in the liquid state, for a longer period of time. . Here, the solidified ozone-dissolved glycerin is an ozone-dissolved glycerin solution in a cooled and solidified state, and the glycerin may be crystallized and solidified, or may become a supercooled state and the viscosity of the entire solution may increase. You may. In addition, glycerin may be solidified alone or may be solidified together with other components constituting the solution.
[0036] ここで、グリセリン濃度 75wt%以上でオゾン濃度 400ppm以上のオゾン溶存グリセ リン溶液に限らず、任意の濃度のオゾン溶存グリセリン溶液が、冷蔵保存または冷凍 保存することでオゾン濃度をより長期間、高濃度に維持することができる。冷却してォ ゾン溶存グリセリン固化物とする場合も同様である。  [0036] Here, not only ozone-dissolved glycerin solutions having a glycerin concentration of 75 wt% or more and an ozone concentration of 400 ppm or more, but also ozone-dissolved glycerin solutions of any concentration can be stored in a refrigerator or frozen for a longer period of time. , Can be maintained at a high concentration. The same applies to the case where it is cooled to obtain a solid ozone-dissolved glycerin.
[0037] なお、オゾンを濃グリセリンに溶存させることで、グリセリンが酸ィ匕されることも想定さ れるため、今回、原料グリセリン及びオゾン溶存グリセリン溶液の1 H— NMRスペクトル 及び13 C— NMR ^ベクトルを計測し、比較した。その結果、原料グリセリンのスペクトル と、オゾン溶存グリセリン溶液のスペクトルとの間に差異はなぐグリセリンの酸化物は 検出されなかった。したがって、濃グリセリンに高濃度のオゾンを溶存させても、グリセ リンはオゾンにより酸ィ匕されないことがわ力つた。 [0037] Since it is assumed that glycerin is oxidized by dissolving ozone in concentrated glycerin, this time, the 1 H-NMR spectrum and 13 C-NMR ^ of the raw material glycerin and the ozone-dissolved glycerin solution were used. The vectors were measured and compared. As a result, the spectrum of the raw material glycerin Oxide of glycerin was not detected, which is the same as that of the spectrum of the ozone-dissolved glycerin solution. Therefore, it was evident that glycerin was not oxidized by ozone even when high concentration ozone was dissolved in concentrated glycerin.
[0038] また、気体のオゾンの自然半減期は 2時間程度とされて 、るが、オゾン溶存グリセリ ン溶液中のオゾンの半減期は、後述するように、それよりもはるかに長いものであった 。したがって、オゾン溶存グリセリン溶液中のオゾンは気泡の状態で存在するのでは なぐグリセリンに溶存しているものと推定される。実際にオゾン溶存グリセリン溶液を 生成した直後には、多数の気泡を肉眼で観察できる力 数時間放置するとこれらの 気泡は観察されなくなる。  [0038] Although the natural half-life of gaseous ozone is about 2 hours, the half-life of ozone in an ozone-dissolved glycerin solution was much longer as described later. . Therefore, it is presumed that ozone in the ozone-dissolved glycerin solution is dissolved in glycerin, not in the form of bubbles. Immediately after actually producing the ozone-dissolved glycerin solution, if many air bubbles are left for a few hours to allow the naked eye to observe them, these air bubbles will not be observed.
[0039] なお、オゾン溶存グリセリン溶液は用途によってはそのまま使用することもできるが、 化粧水や美容液に利用する場合には、高濃度のグリセリンには肌への刺激性がある ため、グリセリンの濃度を 20wt%以下にすることが好ましい。このため、オゾン溶存グ リセリン溶液に適当な希釈剤を混合して希釈することが好ましい。  [0039] The ozone-dissolved glycerin solution can be used as it is depending on the application. However, when used in a lotion or a serum, the high concentration of glycerin is irritating to the skin. Preferably, the concentration is 20 wt% or less. For this reason, it is preferable to dilute the ozone-dissolved glycerin solution by mixing it with an appropriate diluent.
[0040] このような希釈剤としては、オゾンにより酸敗しにくいものが適しており、水、ワセリン 、ポリエチレングリコールなどが適している。水を希釈剤とする場合は、純水または超 純水を使用することが好ましい。水に不純物が混入していると、オゾンに酸化されて 皮膚に刺激を与えたり薬効を低下させたりする酸化物 (過酸化物)が生成される恐れ があるためである。  [0040] As such a diluent, those which are not easily rancid by ozone are suitable, and water, petrolatum, polyethylene glycol and the like are suitable. When water is used as the diluent, it is preferable to use pure water or ultrapure water. If water contains impurities, it can be oxidized by ozone and produce oxides (peroxides) that irritate the skin and reduce its efficacy.
[0041] ワセリンを使用する場合は、不純物が少なく酸敗されにくい精製ワセリンを用いるこ とが好ま 、。不純物があるとオゾンに酸化されて皮膚に刺激を与えたり薬効を低下 させたりする酸化物 (過酸化物)が生成される力もである。このような精製ワセリンとし ては、丸石製薬社製のプロぺト (登録商標)や、 日興リカ社製のサンホワイト (登録商 標)等を用いることができる。  [0041] When petrolatum is used, it is preferable to use purified petrolatum which contains few impurities and is hardly rancid. Impurities are also oxidized to ozone, which also produces oxides (peroxides) that irritate the skin and reduce drug efficacy. As such purified petrolatum, Proto (registered trademark) manufactured by Maruishi Pharmaceutical Co., Ltd., Sun White (registered trademark) manufactured by Nikko Rica Co., Ltd., or the like can be used.
[0042] ポリエチレングリコールを使用する場合は、 日本薬局方で定められたマクロゴール 軟膏を用いることが望ましい。マクロゴール軟膏は、液体のマクロゴール 400と固体の マクロゴール 4000とをほぼ 1: 1で混合したものである力 用途に応じて粘度を調整 するために混合比を適宜変更してもよい。また、粘度を調整するために高分子剤を 添加してもよい。マクロゴールには吸湿性があるため、グリセリンと混合することで保 湿性が高 、軟膏とすることができる。 When using polyethylene glycol, it is desirable to use Macrogol ointment specified by the Japanese Pharmacopoeia. The macrogol ointment is a mixture of liquid macrogol 400 and solid macrogol 4000 at a ratio of approximately 1: 1. The mixing ratio may be appropriately changed in order to adjust the viscosity according to the power application. Further, a polymer agent may be added to adjust the viscosity. Macrogol is hygroscopic and can be preserved by mixing with glycerin. It is highly wet and can be used as an ointment.
[0043] これらの希釈剤でオゾン溶存グリセリン溶液を希釈したオゾン溶存混合溶液は、ォ ゾン濃度が 80ppm以上であることが好ま U、。オゾン濃度が 80ppm以上であれば、 殺菌能力を発揮することができる。また、オゾン濃度が lOOppm以上であれば、より 殺菌能力を発揮することができる。さらに、オゾン濃度が 500ppm以上であれば、創 傷治癒効果を得ることができ、オゾン濃度が lOOOppm以上であれば、後述するよう に、優れた創傷治癒効果を発揮することができる。  [0043] The ozone-dissolved mixed solution obtained by diluting the ozone-dissolved glycerin solution with these diluents preferably has an ozone concentration of 80 ppm or more. If the ozone concentration is 80 ppm or more, the sterilizing ability can be exhibited. Further, when the ozone concentration is 100 ppm or more, the sterilizing ability can be more exhibited. Further, when the ozone concentration is 500 ppm or more, a wound healing effect can be obtained, and when the ozone concentration is 100 ppm or more, an excellent wound healing effect can be exhibited as described later.
[0044] 上記のオゾン溶存混合溶液もまた、 5°C以上 10°C以下で冷蔵保存または 5°C以 下で冷凍保存することで、オゾン溶存混合溶液力 放出されるオゾンの量をさらに少 なくすることができ、常温保存するよりもオゾン濃度をより長期間、高濃度に維持する ことができる。  [0044] The above ozone-dissolved mixed solution is also stored in a refrigerator at 5 ° C or more and 10 ° C or less or frozen and stored at 5 ° C or less to further reduce the amount of ozone released from the ozone-dissolved mixed solution. The ozone concentration can be maintained at a higher level for a longer period of time than when stored at room temperature.
[0045] また、オゾン溶存混合溶液も、オゾン溶存グリセリン溶液と同様に、冷却してオゾン 溶存グリセリン固化物とすることができる。オゾン溶存グリセリン固化物とした場合には [0045] Further, the ozone-dissolved mixed solution can also be cooled to obtain an ozone-dissolved glycerin solidified product, similarly to the ozone-dissolved glycerin solution. In the case of solidified ozone-dissolved glycerin,
、液体の状態よりもオゾンが放出されにくぐオゾン濃度をより長期間、高濃度に維持 することができる。 In addition, the ozone concentration at which ozone is released more easily than in the liquid state can be maintained at a high concentration for a longer period.
[0046] <実施例 1 > <Example 1>
濃グリセリンとオゾンとを気液接触させ、オゾン溶存グリセリン溶液を製造した。ここ で、濃グリセリンとは、 日本薬局方品の 98wt%以上の濃度のグリセリンを意味する。  Concentrated glycerin and ozone were brought into gas-liquid contact to produce an ozone-dissolved glycerin solution. Here, the concentrated glycerin means glycerin having a concentration of 98 wt% or more of the Japanese Pharmacopoeia product.
[0047] 接触槽として、容量 50Lのテフロン (登録商標)製タンクを用いた。タンクの底面に 散気管を設置し、オゾンを微細な気泡としてタンク内に供給することができるようにし た。オゾン発生装置には、 90%以上の濃度の酸素を原料として毎時 lOOgのオゾン 発生能力を有する無声放電式オゾン発生装置を使用した。 [0047] As the contact tank, a Teflon (registered trademark) tank having a capacity of 50 L was used. An air diffuser was installed at the bottom of the tank so that ozone could be supplied as fine bubbles into the tank. The ozone generator used was a silent discharge ozone generator with an ozone generation capacity of 100 g / h using oxygen with a concentration of 90% or more as a raw material.
[0048] タンクに 22kgの濃グリセリンを入れ、オゾン発生装置に毎分 20Lの酸素を送り込み[0048] 22 kg of concentrated glycerin is put into the tank, and 20 L of oxygen is fed into the ozone generator per minute.
、発生したオゾンを含む気体を散気管からタンク内に 7日間放出し、終濃度 3000pp mのオゾン濃度のオゾン溶存グリセリン溶液を得た。 The generated gas containing ozone was released from the air diffuser tube into the tank for 7 days to obtain an ozone-dissolved glycerin solution having an ozone concentration of 3000 ppm final.
[0049] 得られたオゾン溶存グリセリン溶液を常温、冷蔵 (約 5°C)、冷凍 (約—20°C)の!、ず れかで保存し、オゾン濃度の半減期を計測した。オゾン濃度の測定にはヨウ化力リウ ム適定法を用いた。 [0050] 得られたオゾン溶存グリセリン溶液を常温で保存したところ、約 6ヶ月でオゾン濃度 が半減した。また、冷蔵時には、約 16ヶ月でオゾン濃度が半減した。また、 3年間冷 凍保存したところ、オゾン濃度の変化率は 98%であり、ほとんど変化しな力つた。これ は、冷凍することでオゾン溶存グリセリン溶液のグリセリンが結晶化したため、あるい は溶液全体の粘性が高くなつたため、液体の状態よりもオゾンが放出されに《なつ たと考えられる。 [0049] The obtained ozone-dissolved glycerin solution was stored at room temperature, refrigerated (about 5 ° C), and frozen (about -20 ° C)! , And the half-life of the ozone concentration was measured. The measurement of ozone concentration was carried out using the method for determining the amount of lithium iodide. [0050] When the obtained ozone-dissolved glycerin solution was stored at room temperature, the ozone concentration was reduced by half in about 6 months. During refrigeration, the ozone concentration was reduced by half in about 16 months. After three years of refrigeration, the rate of change in ozone concentration was 98%, indicating almost no change. This is thought to be because the glycerin in the ozone-dissolved glycerin solution crystallized due to freezing, or the viscosity of the entire solution became higher, and ozone was not released than in the liquid state.
[0051] <実施例 2>  <Example 2>
濃グリセリンから上記製造方法にて製造されたオゾン溶存グリセリン溶液 (以下、ォ ゾンジエルと 、う)及びこれにマクロゴール軟膏を混合したオゾン溶存混合溶液(以下 、オゾン軟膏という)と、強電解酸性ジエル、電解酸性機能水と比較検討した。  An ozone-dissolved glycerin solution (hereinafter referred to as ozondiel) produced from concentrated glycerin by the above-described method, an ozone-dissolved mixed solution obtained by mixing macrogol ointment (hereinafter referred to as ozone ointment), and a strong electrolytic acid jell And electrolyzed acidic functional water.
[0052] 〔実験材料〕  [Experimental Materials]
4週齢雄性 Wistar系ラットを 16匹、オゾン軟膏 (VMC社製)、比較対照としてォゾ ンジエル (VMC社製)、強電解酸性ジエル(MIZ社製)、電解酸性機能水(OXILIZE R (登録商標)、三浦電子社製)を用いた。  Sixteen 4-week-old male Wistar rats, ozone ointment (VMC), ozone giel (VMC), strong electrolytic acid gir (MIZ), electrolytic acidic functional water (OXILIZE R (registered) (Trademark), manufactured by Miura Electronics Co., Ltd.).
[0053] オゾン軟膏及びオゾンジエルは、ともにオゾンの溶存濃度が lOOOppmに調整して あるものを用いた。強電解酸性ジエルは pH2. 14、酸化還元電位 463mV、有効塩 素濃度 Oppmのソフトタイプを用い、電解酸性機能水は pH2. 14、酸化還元電位 11 57mV、有効塩素濃度 37. 33ppmに調整したものを用いた。  [0053] As the ozone ointment and the ozone diel, those in which the dissolved concentration of ozone was adjusted to 100 ppm were used. The strong electrolytic acid jell is a soft type with pH 2.14, redox potential 463 mV, effective chlorine concentration Oppm, and the electrolytic acidic functional water is adjusted to pH 2.14, redox potential 11 57 mV, effective chlorine concentration 37.33 ppm. Was used.
[0054] 〔実験方法〕  [Experimental method]
ェチルエーテルによりラットに麻酔を施した後、背部の皮膚をヒビテンにて消毒し剃 毛した。その部位にデルマパンチ (スティーフェル'ラボラトリゥム社製)を用いて、直 径 5mm、深さ約 lmmの創傷部位を 4箇所、作製した。各創傷部位に 1日 2回 (AM9 : 00、 PM9 : 00)、オゾン軟膏、オゾンジエル、強電解酸性ジエル、電解酸性機能水 をそれぞれ塗布した。  After the rats were anesthetized with ethyl ether, the skin on the back was disinfected with Hibiten and shaved. Using a Derma Punch (manufactured by Stiefel Laboratorium), four wound sites with a diameter of 5 mm and a depth of about lmm were created. Ozone ointment, ozone jewel, strong electrolytic acidic jewel, and electrolytic acidic functional water were applied to each wound site twice a day (AM 9:00, PM 9:00).
[0055] 創傷部位作製 1、 3、 5、 7日目にラットの創傷部位の直径を計測し、その後直ちに 屠殺し試料を採取した。なお、直径の計測は 1つの少々部位につき 4箇所で行い、そ の平均値を計測結果とした。  Preparation of Wound Site The diameter of the wound site of the rat was measured on days 1, 3, 5, and 7, and immediately thereafter, the rat was sacrificed and a sample was collected. The measurement of the diameter was performed at four places for one small part, and the average value was used as the measurement result.
[0056] 採取した試料をパラフィン包埋し、切片を作製した後、 HE染色を施し、試料の上皮 の再生度、肉芽組織の形成度を観察した。また、ァザン染色を行い、創傷治癒過程 における膠原繊維の増殖度を検討した。 [0056] The collected sample was embedded in paraffin to prepare a section, which was then subjected to HE staining, and the epithelium of the sample was analyzed. And the formation of granulation tissue were observed. In addition, Azan staining was performed to examine the degree of proliferation of collagen fibers during the wound healing process.
[0057] 〔結果及び考察〕 [Results and Discussion]
< <肉眼的な観察 > >  <<Visual observation>>
< 1日例 >  <1 day>
創傷部位の直径の縮小率は、電解酸性機能水では 98. 1%、強電解酸性ジエルで は 93. 5%、オゾンジエルでは 98. 0%、オゾン軟膏では 94. 3%であったが、有意差 は認められなかった。  The reduction rate of the diameter of the wound site was 98.1% for the electrolyzed acidic functional water, 93.5% for the strongly electrolyzed acidic jewel, 98.0% for the ozone jewel, and 94.3% for the ozone ointment. No difference was observed.
[0058] < 3日例 > [0058] <3 days>
創傷部位の直径の縮小率は、電解酸性機能水では 82. 5%、強電解酸性ジエルで は 82. 5%、オゾンジエルでは 80. 5%、オゾン軟膏では 86. 5%であったが、有意差 は認められなかった。  The rate of reduction of the diameter of the wound site was 82.5% for the electrolyzed acidic functional water, 82.5% for the strongly electrolyzed acidic jewel, 80.5% for the ozone jewel, and 86.5% for the ozone ointment. No difference was observed.
[0059] < 5日例 > [0059] <5 days>
創傷部位の直径の縮小率は、電解酸性機能水では 70. 5%、強電解酸性ジエルで は 66. 5%、オゾンジエルでは 63. 5%、オゾン軟膏では 63. 0%であったが、有意差 は認められなかった。  The reduction rate of the diameter of the wound site was 70.5% for the electrolyzed acidic functional water, 66.5% for the strongly electrolyzed acidic jewel, 63.5% for the ozone jewel, and 63.0% for the ozone ointment. No difference was observed.
[0060] < 7日例 > [0060] <7th day>
創傷部位の直径の縮小率は、電解酸性機能水では 57. 5%、強電解酸性ジエルで は 51. 0%、オゾンジエルでは 44. 0%、オゾン軟膏では 41. 5%であった。電解酸性 機能水とオゾン軟膏、電解酸性機能水とオゾンジエル、強電解酸性ジエルとオゾン軟 膏の間に有意差が認められた。  The reduction rate of the diameter of the wound site was 57.5% for the electrolyzed acidic functional water, 51.0% for the strongly electrolyzed acidic jewel, 44.0% for the ozone jewel, and 41.5% for the ozone ointment. Significant differences were found between the electrolytic acidic functional water and ozone ointment, between the electrolytic acidic functional water and ozone ointment, and between the strong acidic acidic water and ozone ointment.
< < HE染色における組織学的観察 > >  <<Histological observation in HE staining>>
< 1日例、3日例>  <1 day, 3 days>
明らかな差異は認められな力つた。  No apparent difference was found.
[0061] < 5日例 > [0061] <5 days>
3日例と比較し、電解酸性機能水では、肉芽組織の再生を認め、フイブリン層の吸 収促進が見られた。強電解酸性ジエルでは、上皮下に炎症性細胞浸潤を伴う肉芽組 織の形成が見られ、僅かではあるが創傷中心に向力う基底細胞の再生と繊維形成が 認められた。オゾンジエルでは、炎症性細胞浸潤を伴う肉芽組織の形成、創傷部辺 縁より上皮の再生が認められた。オゾン軟膏では、肉芽組織内の炎症性細胞浸潤が やや消退しており、比較的良好な上皮の再生が認められた。 Compared with the three-day case, the regeneration of granulation tissue was observed in the electrolytic acidic functional water, and the absorption of the fibrin layer was promoted. In the strong electrolytic acid jewel, granulation tissue formation with inflammatory cell infiltration was observed in the subepithelium, and although a little, the regeneration of basal cells and the formation of fibers toward the center of the wound were observed. Admitted. In ozone jewels, granulation tissue formation with inflammatory cell infiltration and regeneration of epithelium from the wound margin were observed. In ozone ointment, inflammatory cell infiltration in granulation tissue was slightly abolished, and relatively good epithelial regeneration was observed.
[0062] < 7日例 >  [0062] <7th day>
電解酸性機能水では肉芽組織はやや消退し、郵送細胞の減少が見られた。強電 解酸性ジエルでは上皮下の炎症細胞浸潤はほぼ消退し、線維性結合組織で形成さ れ、毛細血管の形成が見られた。オゾンジエル、オゾン軟膏では、上皮下の炎症性 細胞はほぼ消退しており、毛細血管の豊富な線維性結合組織が形成され、上皮の 再生も良好であった。  The granulated tissue slightly disappeared in the electrolyzed acidic functional water, and the number of mail cells decreased. Subcutaneous epithelial inflammatory cell infiltration almost disappeared in the strong electrolysis acid jewel, and it was formed in fibrous connective tissue, and formation of capillaries was observed. In the case of ozone jewel and ozone ointment, subepithelial inflammatory cells were almost eliminated, fibrous connective tissue rich in capillaries was formed, and epithelial regeneration was also good.
< <ァザン染色における組織学的所見 > >  <<Histological findings in Azan staining>>
< 1日例、3日例>  <1 day, 3 days>
明らかな差異は認められな力つた。  No apparent difference was found.
[0063] く 5日例、 7日例〉 [0063] 5 days, 7 days>
線維性結合組織の再生度は、オゾン軟膏、オゾンジエル、強電解酸性ジエル、電解 酸性機能水の順に良好であることが確認された。  It was confirmed that the degree of fibrous connective tissue regeneration was good in the order of ozone ointment, ozone die, strong electrolytic acidic die, and electrolytic acidic functional water.
[0064] 以上の結果より、オゾン軟膏は、オゾンジエル、強電解酸性ジエルと比較して、肉眼 的な観点力 ほぼ同様な治療経過を呈した。上皮の再生度についても、組織学的に はオゾン軟膏が最も良好で、次いでオゾンジエル、強電解酸性ジエル、電解酸性機 能水の順に良好であった。オゾン軟膏は強電解酸性ジエル、オゾンジエルのように創 傷部への刺激がなぐ塗布しやすい長所を有しているので、創傷部への治療薬とし て応用できる可能性が示唆された。 [0064] From the above results, ozone ointment exhibited almost the same visual course of treatment as ozone diels and strong electrolytic acid diels. Regarding the degree of epithelial regeneration, histologically, ozone ointment was the best, followed by ozone die, strong electrolytic acidic die, and electrolytic acidic functional water in this order. Ozone ointment has the advantage that it can be easily applied to wounds like strong electrolytic acid jewels and ozone jewels, suggesting that it can be applied as a therapeutic agent to wounds.
産業上の利用可能性  Industrial applicability
[0065] 本発明を適用したオゾン軟膏は、創傷部への刺激がなぐ塗布しやすい長所を有 して 、るので、創傷部への治療薬として応用できる。 [0065] The ozone ointment to which the present invention has been applied has an advantage that it can be easily applied to the wound area, and therefore can be applied as a therapeutic agent to the wound area.

Claims

請求の範囲 The scope of the claims
[1] 75wt%以上の非酸ィ匕のグリセリン溶液にオゾン力 OOppm以上溶存して 、ること を特徴とするオゾン溶存グリセリン溶液。  [1] An ozone-dissolved glycerin solution characterized in that ozone power of OO ppm or more is dissolved in a non-oxidizing glycerin solution of 75 wt% or more.
[2] 75wt%以上の非酸化のグリセリン溶液にオゾン力 OOppm以上溶存して!/、るォゾ ン溶存グリセリン溶液を水、ワセリン、ポリエチレングリコールのいずれ力 1つと混合し てなり、オゾンが 80ppm以上溶存して 、ることを特徴とするオゾン溶存混合溶液。 [2] Ozone power of OOppm or more dissolved in non-oxidized glycerin solution of 75wt% or more! /, Luzon-dissolved glycerin solution is mixed with any one of water, petrolatum or polyethylene glycol, and 80ppm of ozone An ozone-dissolved mixed solution characterized by being dissolved as described above.
[3] 75wt%以上のグリセリン溶液に、オゾンを含むガスを気液接触させてオゾンを 400 ppm以上溶存させることを特徴とするオゾン溶存グリセリン溶液の製造方法。 [3] A method for producing an ozone-dissolved glycerin solution, characterized in that ozone-containing gas is brought into gas-liquid contact with 75% by weight or more of glycerin solution to dissolve 400 ppm or more of ozone.
[4] 75wt%以上のグリセリン溶液にオゾンを含むガスを気液接触させてオゾンを 400p pm以上溶存させ、これと、水、ワセリン、ポリエチレングリコールのいずれ力 1つとを混 合し、攪拌することでオゾンを 80ppm以上溶存させることを特徴とするオゾン溶存混 合溶液の製造方法。 [4] A gas containing ozone is brought into gas-liquid contact with a 75 wt% or more glycerin solution to dissolve ozone at 400 ppm or more, and mixed with any one of water, petrolatum, or polyethylene glycol and stirred. A method for producing an ozone-dissolved mixed solution, comprising dissolving 80 ppm or more of ozone in the above step.
[5] 非酸ィ匕のグリセリン溶液にオゾンが溶存しているオゾン溶存グリセリン溶液を、冷蔵 保存または冷凍保存することを特徴とするオゾン溶存グリセリン溶液の保存方法。  [5] A method for preserving an ozone-dissolved glycerin solution, which comprises refrigerated or frozen storage of an ozone-dissolved glycerin solution in which ozone is dissolved in a non-oxidizing glycerin solution.
[6] 非酸ィ匕のグリセリン溶液にオゾンが溶存して 、るオゾン溶存グリセリン溶液を冷却し 、固化させたことを特徴とするオゾン溶存グリセリン固化物。  [6] An ozone-dissolved glycerin solidified product obtained by dissolving ozone in a non-oxidizing glycerin solution and cooling and solidifying the ozone-dissolved glycerin solution.
PCT/JP2005/002570 2004-02-20 2005-02-18 Glycerol solution containing dissolved ozone, solidified glycerol containing dissolved ozone, mixed solution containing dissolved ozone, process for producing glycerol solution containing dissolved ozone, process for producing mixed solution containing dissolved ozone, and method of storing glycerol solution containing diss WO2005079818A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004044088A JP4677192B2 (en) 2004-02-20 2004-02-20 Method for producing ozone-dissolved glycerin solution
JP2004-044088 2004-02-20

Publications (1)

Publication Number Publication Date
WO2005079818A1 true WO2005079818A1 (en) 2005-09-01

Family

ID=34879328

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2005/002570 WO2005079818A1 (en) 2004-02-20 2005-02-18 Glycerol solution containing dissolved ozone, solidified glycerol containing dissolved ozone, mixed solution containing dissolved ozone, process for producing glycerol solution containing dissolved ozone, process for producing mixed solution containing dissolved ozone, and method of storing glycerol solution containing diss

Country Status (3)

Country Link
JP (1) JP4677192B2 (en)
TW (1) TW200603819A (en)
WO (1) WO2005079818A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010531320A (en) * 2007-06-28 2010-09-24 ボーデ ヒェミー ゲゼルシャフト ミット ベシュレンクテル ハフツング Use of the synergistic composition as a therapeutic or disinfectant
CN110559189A (en) * 2019-08-20 2019-12-13 安徽氧趣生物科技有限公司 Preparation method of dimer and polymer ozone ointment
EP3466447A4 (en) * 2016-05-30 2020-03-18 Fu, Yuanqiao Topical pharmaceutical composition for treating multiple forms of skin wounds and manufacturing method thereof
CN115515670A (en) * 2020-03-19 2022-12-23 昂萨公司 Delivery of gas phase antimicrobials via injected crystalline and porous solids
WO2023057989A3 (en) * 2021-10-07 2023-08-03 Roberto Albertelli A method and an apparatus for making a treatment solution and for providing said treatment solution to a biological system

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4873755B2 (en) * 2006-06-16 2012-02-08 株式会社E・テック Disinfectant containing ozone
JP2009001575A (en) * 2008-06-23 2009-01-08 Ozotech:Kk Agent for external use containing ozone-dissolved glycerol solution such as cosmetic, quasi-drug or medicament (pharmaceutical)
WO2019098241A1 (en) * 2017-11-16 2019-05-23 株式会社メディプラス製薬 Pharmaceutical composition for mastitis, and medical treatment method

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10139645A (en) * 1996-11-14 1998-05-26 Merubuaisu:Kk Ozone-including viscous substance and its generator
WO2002100455A2 (en) * 2001-06-08 2002-12-19 Baylor College Of Medicine Use of ozone for the prevention of infection caused by medical devices
JP2003055107A (en) * 2001-08-10 2003-02-26 Vmc Co Ltd Water-soluble germicide and method for producing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05301819A (en) * 1992-04-22 1993-11-16 Nippon Nature Roman:Kk Antiphlogistic agent for atopic dermatitis, apparatus for producing the same antiphlogistic agent and its production

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10139645A (en) * 1996-11-14 1998-05-26 Merubuaisu:Kk Ozone-including viscous substance and its generator
WO2002100455A2 (en) * 2001-06-08 2002-12-19 Baylor College Of Medicine Use of ozone for the prevention of infection caused by medical devices
JP2003055107A (en) * 2001-08-10 2003-02-26 Vmc Co Ltd Water-soluble germicide and method for producing the same

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010531320A (en) * 2007-06-28 2010-09-24 ボーデ ヒェミー ゲゼルシャフト ミット ベシュレンクテル ハフツング Use of the synergistic composition as a therapeutic or disinfectant
EP3466447A4 (en) * 2016-05-30 2020-03-18 Fu, Yuanqiao Topical pharmaceutical composition for treating multiple forms of skin wounds and manufacturing method thereof
US10864240B2 (en) 2016-05-30 2020-12-15 Yuanqiao Fu Pharmaceutical composition for treating skin wounds and a method of treating skin wounds using thereof
US11571452B2 (en) 2016-05-30 2023-02-07 Yuanqiao Fu Method of treating a skin wound with a liquid-state topical pharmaceutical composition
CN110559189A (en) * 2019-08-20 2019-12-13 安徽氧趣生物科技有限公司 Preparation method of dimer and polymer ozone ointment
CN115515670A (en) * 2020-03-19 2022-12-23 昂萨公司 Delivery of gas phase antimicrobials via injected crystalline and porous solids
WO2023057989A3 (en) * 2021-10-07 2023-08-03 Roberto Albertelli A method and an apparatus for making a treatment solution and for providing said treatment solution to a biological system

Also Published As

Publication number Publication date
JP2005232094A (en) 2005-09-02
TW200603819A (en) 2006-02-01
JP4677192B2 (en) 2011-04-27

Similar Documents

Publication Publication Date Title
WO2005079818A1 (en) Glycerol solution containing dissolved ozone, solidified glycerol containing dissolved ozone, mixed solution containing dissolved ozone, process for producing glycerol solution containing dissolved ozone, process for producing mixed solution containing dissolved ozone, and method of storing glycerol solution containing diss
US20170202877A1 (en) Hypochlorite formulations for wound healing
EP1162176B1 (en) Electrolyzed water of anode side and process for production thereof
US5407656A (en) Method and compositions for the production of chlorine dioxide
MX2010011189A (en) Method of producing composition of hypochlorous acid and use thereof.
JP2003517463A (en) Disinfection compositions based on H2O2, acids and metal ions
CN102395526B (en) Nonaqueous chlorine dioxide-generating compositions and methods related thereto
KR20190139199A (en) Oral Biofilm Remover and Oral Composition
US20130323326A1 (en) Method for suppressing or preventing fibrous adhesion formation using a multicomponent aqueous oxychlorine composition prepared on-site
JP2005232094A5 (en)
KR20160042209A (en) Method of manufacturing ozonized composition of oil, and ozonized composition of oil manufactured by using the same
CN1579364A (en) Emulsified salt type skin-cleaning product and its preparation method
US20160317577A1 (en) Electrolyzed saline redox-balanced compositions and methods for treating skin conditions
KR102397070B1 (en) Formulations of calcium and phosphate for oral inflammation
JPWO2008050676A1 (en) Glycerol suspension of ascorbic acid and method for producing the same
JP5222344B2 (en) Ozone-dissolved glycerin solution, ozone-dissolved glycerin solidified product, ozone-dissolved mixed solution, method for producing ozone-dissolved glycerin solution, method for producing ozone-dissolved mixed solution, and method for storing ozone-dissolved glycerin solution
JP2004261656A (en) Manufacturing method for mixed electrolytic water
US20040180015A1 (en) Long-acting disinfecting nitrous acid compositions and related processes
JP2003306407A (en) Reductive aqueous composition, cosmetic and use of the same
US20150056304A1 (en) Gel, in particular for use in a wound treatment agent
US20030175362A1 (en) Disinfecting nitrous acid compositions and process for using the same
JP2008013493A (en) Method for storing glycerol solution containing ascorbic acid in high concentration
US20150209470A1 (en) Oxygenated Oil Ointment
CN111743793A (en) Hand sanitizer and preparation method thereof
US10259712B2 (en) Method of stabilizing compounds in water, water compositions thereby, and articles containing said water compositions

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase